Budget Impact of Prophylactic Letermovir to Prevent Cytomegalovirus Disease in High-Risk Adult Kidney Transplant Recipients.

Valcyte (valganciclovir) - Roche, Tanabe Pharma

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42732038

Abdel Hmissi; Andrew Beyer; Irina Kolobova; Lei Ai; Michael Wong; Murvin Jootun; Qinghua Li; Vladimir Turzhitsky

Sep 13, 2026